Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Sulfasalazine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 43Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    The Association of Methotrexate, Sulfasalazine and Hydroxychloroquine Use
    The Association of Methotrexate, Sulfasalazine and Hydroxychloroquine Use

    09 Nov 2020

    // ACRABSTRACTS

    https://acrabstracts.org/abstract/the-association-of-methotrexate-sulfasalazine-and-hydroxychloroquine-use-with-incident-fractures-in-postmenopausal-women-with-rheumatoid-arthritis-findings-from-the-womens-health-initiative/

    ACRABSTRACTS
    09 Nov 2020
    Share Share
    Generic Version of Delzicol® Delayed-Release Capsules Launched in the US
    Generic Version of Delzicol® Delayed-Release Capsules Launched in the US

    10 May 2019

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20190510005380/en/Teva-Announces-Launch-Generic-Version-Delzicol%C2%AE-mesalamine

    BUSINESSWIRE
    10 May 2019
    Share Share
    DCGI directs state DCs to ask manufacturers of 7 drugs, identified ADRs drugs
    DCGI directs state DCs to ask manufacturers of 7 drugs, identified ADRs drugs

    12 Apr 2019

    // PHARMABIZ

    http://pharmabiz.com/ArticleDetails.aspx?aid=115187&sid=1

    PHARMABIZ
    12 Apr 2019
    Share Share
    Health Canada Issues Recall of Pharmascience`s PMS-Sulfasalazine 500 mg Tablet USP
    Health Canada Issues Recall of Pharmascience`s PMS-Sulfasalazine 500 mg Tablet USP

    10 Apr 2019

    // HEALTH CANADA

    https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2019/69612r-eng.php

    HEALTH CANADA
    10 Apr 2019
    Share Share
    GSK announces positive results from two phIII studies of sirukumab
    GSK announces positive results from two phIII studies of sirukumab

    18 Nov 2016

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=98747&sid=2

    PHARMABIZ
    18 Nov 2016
    Share Share